Overview

A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355

Status:
Completed
Trial end date:
2019-08-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of CKD-355.
Phase:
Phase 1
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Memantine